Core Scientific stock
CORZNASDAQCore Scientific, Inc., TechnologyISIN US21874A1060
33Score 33 out of 100, Weak
We are checking this figure against the original source: earnings per share.
Price and trend
42 / 100
Price history
−16% in one yearThe chart shows daily closes over 3 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 25% below it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 56).
The price is 50% below its 52-week high. Largest decline in 3 years: 65% (November 2024 to April 2025).
Chart figures for advanced users
- SMA 50$15.51
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$19.42
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)56
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$11.38
- The lowest closing price of the last twelve months.
- Resistance$29.16
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Core Scientific, Inc. belongs to the Software (Infrastructure) industry (United States) and, with a market value of $4.69B, is number 52 of 97 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $319.02M (down 37.5% year on year) and a loss of $288.62M.
- For fiscal 2026, analysts expect on average revenue of $686.8M (up 115.3%) and adjusted earnings per share of −$4.28.
Show more
- MEQIRI Score 33 out of 100 (Weak): rank 813 of 857 in Technology, median 61.
- Our model puts fair value at $4.54, with the price 221% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 39.5% a year since 2020, Software (Infrastructure) median 18%.Growth 70
- Share buybacksShare count down 16% since 2020.Capital allocation 51
Weaknesses
- Above fair valuePrice 221% above the fair value of $4.54.Valuation 20
- Loss-makingLoss of $110.22M over the last 12 months.Fundamentals 17
- Negative free cash flowFree cash flow −$1.32B over the last 12 months.Fundamentals 17
Its standout strength is growth, while fundamentals and stability hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 32 to 33.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- weak fundamentals
- high price swings
- price far below its 52-week high
Valuation
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $3.03 and expensive above $9.08 (uncertainty very high, based on the price swings of the past year).
Calculated with a cost of equity of 11.7%. At 12.7% the fair value would be $3.95, at 10.7% it would be $5.31.
Valuation metrics
From the cash-flow model alone; without earnings there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2025, revenue fell 37.5% on the prior year. Revenue has grown strongly since 2019, at around 32% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 12%, operating −70%, net −90%. Last 12 months: net −19%.
Debt & balance sheet
latest quarterDebt is elevated; no interest coverage is reported.
Earnings
- Next earnings
- 1 Mar 2027in 109 days
- Last reported
- 5 Nov 2026EPS reported $0.47 (expected −$0.05)above expectations
Analyst estimates
Analysts have cut their 2027 earnings estimate by 75.3% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- −$4.28+2.9%
- Revenue
- $686.8M+0.6%
- Earnings per share
- $0.07−75.3%
- Revenue
- $1.15B+1.1%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +0.8%No guidance change stated; roughly $2 billion of capital expenditure planned for 2026, with another 200 megawatts expected to earn revenue in the coming months.
“We expect to deploy roughly $2 billion of total capital expenditures in 2026.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 6 May 2026 (fiscal Q1 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
2 insiders bought on the open market in the last 6 months, $342,332 in total. One insider sold, $4.87M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Duchene Todd MSale
2 Nov 2026, See remarks
- Shares
- 10,000
- Price
- $12.78
- Value
- $127,832
- Duchene Todd MSale
26 Oct 2026, See remarks
- Shares
- 10,000
- Price
- $13.56
- Value
- $135,594
- Duchene Todd MSale
19 Oct 2026, See remarks
- Shares
- 10,000
- Price
- $13.87
- Value
- $138,744
Show 24 more
- Duchene Todd MSale
12 Oct 2026, See remarks
- Shares
- 10,000
- Price
- $15.12
- Value
- $151,160
- Duchene Todd MSale
5 Oct 2026, See remarks
- Shares
- 10,000
- Price
- $16.31
- Value
- $163,056
- Duchene Todd MSale
28 Sept 2026, See remarks
- Shares
- 10,000
- Price
- $16.76
- Value
- $167,586
- Duchene Todd MSale
21 Sept 2026, See remarks
- Shares
- 10,000
- Price
- $18.37
- Value
- $183,746
- Weiss Eric StantonPurchase
15 Sept 2026, Board
- Shares
- 6,000
- Price
- $16.33
- Value
- $97,980
- Duchene Todd MSale
14 Sept 2026, See remarks
- Shares
- 10,000
- Price
- $17.14
- Value
- $171,362
- Duchene Todd MSale
8 Sept 2026, See remarks
- Shares
- 10,000
- Price
- $18.67
- Value
- $186,735
- Duchene Todd MSale
31 Aug 2026, See remarks
- Shares
- 10,000
- Price
- $16.23
- Value
- $162,340
- Duchene Todd MSale
24 Aug 2026, See remarks
- Shares
- 10,000
- Price
- $17.45
- Value
- $174,493
- Crain ElizabethPurchase
20 Aug 2026, Board
- Shares
- 6,000
- Price
- $18.33
- Value
- $109,994
- Weiss Eric StantonPurchase
18 Aug 2026, Board
- Shares
- 7,000
- Price
- $19.19
- Value
- $134,358
- Duchene Todd MSale
17 Aug 2026, See remarks
- Shares
- 10,000
- Price
- $20.10
- Value
- $200,974
- Duchene Todd MSale
10 Aug 2026, See remarks
- Shares
- 10,000
- Price
- $19.97
- Value
- $199,735
- Duchene Todd MSale
3 Aug 2026, See remarks
- Shares
- 10,000
- Price
- $22.23
- Value
- $222,340
- Duchene Todd MSale
27 Jul 2026, See remarks
- Shares
- 10,000
- Price
- $20.95
- Value
- $209,476
- Duchene Todd MSale
20 Jul 2026, See remarks
- Shares
- 10,000
- Price
- $22.30
- Value
- $222,995
- Duchene Todd MSale
13 Jul 2026, See remarks
- Shares
- 10,000
- Price
- $22.45
- Value
- $224,475
- Duchene Todd MSale
6 Jul 2026, See remarks
- Shares
- 10,000
- Price
- $22.63
- Value
- $226,254
- Duchene Todd MSale
29 Jun 2026, See remarks
- Shares
- 10,000
- Price
- $26.17
- Value
- $261,658
- Duchene Todd MSale
22 Jun 2026, See remarks
- Shares
- 10,000
- Price
- $29.29
- Value
- $292,939
- Duchene Todd MSale
15 Jun 2026, See remarks
- Shares
- 10,000
- Price
- $28.19
- Value
- $281,935
- Duchene Todd MSale
8 Jun 2026, See remarks
- Shares
- 10,000
- Price
- $26.85
- Value
- $268,481
- Duchene Todd MSale
26 May 2026, See remarks
- Shares
- 10,000
- Price
- $26.25
- Value
- $262,540
- Duchene Todd MSale
18 May 2026, See remarks
- Shares
- 10,000
- Price
- $23.15
- Value
- $231,497
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Core Scientific
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
857 rated companies in Technology
- This company
- 33
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Software (Infrastructure)
The next larger and next smaller companies by market value
- Varonis SystemsVRNS $5.65B45
- BlackBerryBB $5.52B59
- Trend Micro4704.T $5.48B75
- Remitly GlobalRELY $4.89B71
- AmdocsDOX $4.64B59
- Tenable HoldingsTENB $4.49B57
- Shift4 PaymentsFOUR $4.3B51
- Paymentus HoldingsPAY $4.29B74
ETFs that hold Core Scientific
Held by 14 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Global X Blockchain UCITS ETFBLCH | 4.08% | 0.50% | €63.27M |
| HAN-GINS Tech Megatrend Equal Weight UCITS ETF AccT3KE | 0.60% | 0.59% | €96.5M |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.14% | 0.30% | €4.22B |
Show 5 more
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.13% | 0.30% | €2.17B |
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.06% | 0.30% | €185.82M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.05% | 0.43% | €2.48B |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.03% | 0.45% | €1.53B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.02% | 0.35% | €434.1M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 8 May 2026)
- Valuation signal Overvalued since 11 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.